HPV vaccination and cancer prevention.

Aged Cost-Benefit Analysis Female Humans Male Mass Screening / methods Papillomaviridae / immunology Papillomavirus Infections / complications Papillomavirus Vaccines / administration & dosage Uterine Cervical Neoplasms / prevention & control Vaccination
CIN Cancer Cost-effectiveness HPV Vaccine

Journal

Best practice & research. Clinical obstetrics & gynaecology
ISSN: 1532-1932
Titre abrégé: Best Pract Res Clin Obstet Gynaecol
Pays: Netherlands
ID NLM: 101121582

Informations de publication

Date de publication:
May 2020
Historique:
received: 06 11 2019
revised: 25 02 2020
accepted: 26 02 2020
pubmed: 15 4 2020
medline: 2 6 2020
entrez: 15 4 2020
Statut: ppublish

Résumé

Prophylactic vaccines have been found to be highly effective in preventing infection and pre-invasive and invasive cervical, vulvovaginal and anal disease caused by the vaccine types. HPV vaccines contain virus-like particles that lack the viral genome and produce high titres of neutralising antibodies. Although the vaccines are highly effective in preventing infections, they do not enhance clearance of existing infections. Vaccination programmes target prepubertal girls and boys prior to sexual debut as efficacy is highest in HPV naïve individuals. School-based programmes achieve higher coverage, although implementation is country specific. Vaccination of older women may offer some protection and acceleration of impact, although this may not be cost-effective. HPV-based screening will continue for vaccinated cohorts, although intervals may increase.

Identifiants

DOI: 10.1016/j.bpobgyn.2020.02.009 PMID: 32284298
pubmed: 32284298
pii: S1521-6934(20)30036-5
doi: 10.1016/j.bpobgyn.2020.02.009
pii:
doi:

Substances chimiques

Papillomavirus Vaccines 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

109-124

Informations de copyright

Copyright © 2020. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

A Athanasiou (A)

Department of Metabolism, Digestion and Reproduction, Department of Surgery and Cancer, IRDB, Imperial College London, London, UK; West London Gynaecological Cancer Centre, Hammersmith Hospital, Imperial Healthcare NHS Trust, London, UK.

S Bowden (S)

Department of Metabolism, Digestion and Reproduction, Department of Surgery and Cancer, IRDB, Imperial College London, London, UK; West London Gynaecological Cancer Centre, Hammersmith Hospital, Imperial Healthcare NHS Trust, London, UK.

M Paraskevaidi (M)

Department of Metabolism, Digestion and Reproduction, Department of Surgery and Cancer, IRDB, Imperial College London, London, UK.

C Fotopoulou (C)

Department of Metabolism, Digestion and Reproduction, Department of Surgery and Cancer, IRDB, Imperial College London, London, UK; West London Gynaecological Cancer Centre, Hammersmith Hospital, Imperial Healthcare NHS Trust, London, UK.

P Martin-Hirsch (P)

Central Lancashire Teaching Hospitals, Preston, UK.

E Paraskevaidis (E)

University Hospital of Ioannina, Ioannina, Greece; St Mary's Hospital, Imperial Healthcare NHS Trust, London, UK.

M Kyrgiou (M)

Department of Metabolism, Digestion and Reproduction, Department of Surgery and Cancer, IRDB, Imperial College London, London, UK; West London Gynaecological Cancer Centre, Hammersmith Hospital, Imperial Healthcare NHS Trust, London, UK. Electronic address: m.kyrgiou@imperial.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › HPV vaccination and cancer prevention.
questionsmedicales.fr › Organisations et économie des soins de santé › Économie › Coûts et analyse des coûts › Analyse coût-bénéfice › HPV vaccination and cancer prevention.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › HPV vaccination and cancer prevention.
questionsmedicales.fr › Environnement et santé publique › Santé publique › Pratiques en santé publique › Dépistage de masse › HPV vaccination and cancer prevention.
questionsmedicales.fr › Virus › Virus oncogènes › Virus tumoraux à ADN › Papillomaviridae › HPV vaccination and cancer prevention.
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Maladies transmissibles › Maladies sexuellement transmissibles › Maladies sexuellement transmissibles virales › Infections à papillomavirus › HPV vaccination and cancer prevention.
questionsmedicales.fr › Mélanges complexes › Produits biologiques › Vaccins › Vaccins antiviraux › Vaccins contre les papillomavirus › HPV vaccination and cancer prevention.
questionsmedicales.fr › Maladies urogénitales › Tumeurs de l'appareil urogénital › Tumeurs de l'appareil génital féminin › Tumeurs de l'utérus › Tumeurs du col de l'utérus › HPV vaccination and cancer prevention.
questionsmedicales.fr › Environnement et santé publique › Santé publique › Pratiques en santé publique › Prévention primaire › Immunisation › Vaccination › HPV vaccination and cancer prevention.